Patient considerations in the management of mental stress in psoriasis

References

• Mrowietz U, Schmid-Ott G. Schuppenflechte. Was Sie schon immer über Psoriasis wissen wollten (What You Always Wanted to Know About Psoriasis). 3rd ed. Basel: Karger; 2011. (German)
   Google Scholar
• Nast A, Boehncke W, Mrowietz U, et al. S3-guidelines for the treatment of psoriasis vulgaris. Update 2011 German. JDtsch Dermatol Ges. 2011; 9 Suppl 2:S1-S104.
   Google Scholar
• Rapp SR, Exum ML, Reboussin DM, et al. The physical, psychological and social impact of psoriasis. J Health Psychol. 1997;2:525–537.
   PubMedGoogle Scholar
• Fortune DG, Richards HL, Griffiths CE. Psychologic factors in psoriasis: consequences, mechanisms, and interventions. Dermatol Clin. 2005;23:681–694.
   PubMed Web of Science ®Google Scholar
• Kimball AB, Jacobson C, Weiss S, et al. The psychosocial burden of psoriasis. Am J Clin Dermatol. 2005;6:383–392.
   PubMed Web of Science ®Google Scholar
• Magin P, Adams J, Heading G, et al. The psychological sequelae of psoriasis: results of a qualitative study. Psychol Health Med. 2009;14:150–161.
   PubMed Web of Science ®Google Scholar
• Schmid-Ott G, Malewski P, Kreiselmaier I, Mrowietz U. Psychosocial consequences of psoriasis - an empirical study of disease burden in 3753 affected people. Hautarzt. 2005;56:466–472. German.
   PubMed Web of Science ®Google Scholar
• Misery L, Thomas L, Jullien D, et al. Comparative study of stress and quality of life in outpatients consulting for different dermatoses in 5 academic departments of dermatology. Eur J Dermatol. 2008;18:412–415.
   Web of Science ®Google Scholar
• Rapp SR, Feldman SR, Exum ML, et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41:401–407.
   PubMed Web of Science ®Google Scholar
• Weiss SC, Kimball AB, Liewehr DJ, et al. Quantifying the harmful effect of psoriasis on health-related quality of life. J Am Acad Dermatol. 2002;47:512–518.
   PubMed Web of Science ®Google Scholar
• Reimus JL, Vingerhoets AJ, Soons PH, Korstanje MJ. Suffering in psoriasis patients: its relation with illness severity and subjective well-being. Int J Dermatol. 2007;46:1042–1045.
   PubMed Web of Science ®Google Scholar
• Ashcroft DM, Li Wan PA, Williams HC, Griffiths CE. Quality of life measures in psoriasis: a critical appraisal of their quality. J Clin Pharm Ther. 1998;23:391–398.
   PubMed Web of Science ®Google Scholar
• McKenna KE, Stern RS. The outcomes movement and new measures of the severity of psoriasis. J Am Acad Dermatol. 1996;34:534–538.
   PubMed Web of Science ®Google Scholar
• Gottlieb AB, Chaudhari U, Baker DG, et al. The National Psoriasis Foundation Psoriasis Score (NPF-PS) system versus the Psoriasis Area Severity Index (PASI) and Physician’s Global Assessment (PGA): a comparison. J Drugs Dermatol. 2003;2:260–266.
   PubMedGoogle Scholar
• Schmitt J, Wozel G. The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology. 2005;210:194–199.
   PubMed Web of Science ®Google Scholar
• Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–216.
   PubMed Web of Science ®Google Scholar
• Chren MM, Lasek RJ, Quinn LM, et al. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol. 1996;107:707–713.
   PubMed Web of Science ®Google Scholar
• Basavaraj KH, Navya MA, Rashmi R. Stress and quality of life in psoriasis: an update. Int J Dermatol. 2011;50:783–792.
   PubMed Web of Science ®Google Scholar
• Reich A, Hrehorow E, Szepietowski JC. Pruritus is an important factor negatively influencing the well-being of psoriatic patients. Acta Derm Venereol. 2010;90:257–263.
   PubMed Web of Science ®Google Scholar
• Ljosaa TM, Mork C, Stubhaug A, et al. Skin pain and skin discomfort is associated with quality of life in patients with psoriasis. J Eur Acad Dermatol Venereol. 2012;26:29–35.
   PubMed Web of Science ®Google Scholar
• Hrehorow E, Salomon J, Matusiak L, et al. Patients with psoriasis feel stigmatized. Acta Derm Venereol 2011;92:67–72.
   Web of Science ®Google Scholar
• Perrott SB, Murray AH, Lowe J, Mathieson CM. The psychosocial impact of psoriasis: physical severity, quality of life, and stigmatization. PhysiolBehav. 2000;70:567–571.
   PubMed Web of Science ®Google Scholar
• Schmid-Ott G, Burchard R, Niederauer HH, et al. Stigmatisierungsgefühl und Lebensqualität bei Patienten mit Psoriasis und Neurodermitis. (Stigmatization and quality of life of patients with psoriasis and atopic dermatitis). Hautarzt. 2003;54:852–857. (German)
   PubMedGoogle Scholar
• Ginsburg IH, Link BG. Feelings of stigmatization in patients with psoriasis. J Am Acad Dermatol. 1989;20:53–63.
   PubMed Web of Science ®Google Scholar
• Gupta MA, Gupta AK, Watteel GN. Perceived deprivation of social touch in psoriasis is associated with greater psychologic morbidity: an index of the stigma experience in dermatologic disorders. Cutis. 1998;61:339–342.
   PubMed Web of Science ®Google Scholar
• Richards HL, Fortune DG, Griffiths CE, Main CJ. The contribution of perceptions of stigmatisation to disability in patients with psoriasis. JPsychosom Res. 2001;50:11–15.
   PubMed Web of Science ®Google Scholar
• Böhm D, Stock Gissendanner S, Snitjer K, et al. Perceived relationships between severity of psoriasis symptoms, gender, stigmatization and quality of life. J Eur Acad Dermatol Venereol. Epub February 14, 2012.
   Google Scholar
• Schmid-Ott G, Kunsebeck HW, Jager B, et al. Significance of the stigmatization experience of psoriasis patients: a 1-year follow-up of the illness and its psychosocial consequences in men and women. Acta Derm Venereol. 2005;85:27–32.
   PubMed Web of Science ®Google Scholar
• Schmid-Ott G, Jaeger B, Boehm T, et al. Immunological effects of stress in psoriasis. Br J Dermatol. 2009;160:782–785.
   Web of Science ®Google Scholar
• Zachariae R, Zachariae H, Blomqvist K, et al. Self-reported stress reactivity and psoriasis-related stress of Nordic psoriasis sufferers. J Eur Acad Dermatol Venereol 2004;18:27–36.
   Google Scholar
• Vardy D, Besser A, Amir M, et al. Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. Br J Dermatol. 2002;147:736–742.
   PubMed Web of Science ®Google Scholar
• Farber EM, Nall L. Psoriasis: a stress-related disease. Cutis. 1993;51:322–326.
   PubMed Web of Science ®Google Scholar
• Russo PA, Ilchef R, Cooper AJ. Psychiatric morbidity in psoriasis: a review. Australas JDermatol. 2004;45:155–159.
   PubMedGoogle Scholar
• van Dongen N. Let’s be effective, let the patients talk! Does ‘patient intelligence’ have an effect on improvements in quality within the healthcare environment? Patient Intell. 2009;1:1–5.
   Google Scholar
• Richards HL, Fortune DG, Griffiths CE. Adherence to treatment in patients with psoriasis. J Eur Acad Dermatol Venereol. 2006;20:370–379.
   PubMed Web of Science ®Google Scholar
• Krueger G, Koo J, Lebwohl M, et al. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient- membership survey. Arch Dermatol. 2001;137:280–284.
   PubMed Web of Science ®Google Scholar
• Zaghloul SS, Goodfield MJ. Objective assessment of compliance with psoriasis treatment. Arch Dermatol. 2004;140:408–414.
   PubMed Web of Science ®Google Scholar
• Bewley A, Page B. Maximizing patient adherence for optimal outcomes in psoriasis. J Eur Acad Dermatol Venereol 2011;25 Suppl 4:9–14.
   Google Scholar
• Zautra AJ. Resilience: one part recovery, two parts sustainability. J Pers. 2009;77:1935–1943.
   PubMed Web of Science ®Google Scholar
• Fortune DG, Richards HL, Griffiths CE, Main CJ. Adversarial growth in patients undergoing treatment for psoriasis: a prospective study of the ability of patients to construe benefits from negative events. Psychol Health Med. 2005;10:44–56.
   Google Scholar
• Schmid-Ott G, Jager B, Kunsebeck HW, et al. Illness experience and treatment seeking behavior of psoriasis patients. Hautarzt. 1997;48:547–555. German.
   Google Scholar
• Schaarschmidt ML, Schmieder A, Umar N, et al. Patient preferences for psoriasis treatments: process characteristics can outweigh outcome attributes. Arch Dermatol. 2011;147:1285–1294.
   PubMed Web of Science ®Google Scholar
• Schmid-Ott G, Keins P, Fartasch M, et al. Atopic eczema prevention program in childhood and adolescence - a model project of the German government. Dermatol Psychosom. 2000;1:179–182.
   Google Scholar
• Farber EM, Nall L. The office visit and the self-help concept in treating the patient with psoriasis: a strategy revisited. Cutis. 1993;51:236–240.
   Web of Science ®Google Scholar
• Fortune DG, Richards HL, Kirby B, et al. A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy. Br J Dermatol. 2002;146:458–465.
   PubMed Web of Science ®Google Scholar
• Tan J, Stacey D, Fung K, et al. Treatment decision needs of psoriasis patients: cross-sectional survey. J Cutan Med Surg. 2010;14:233–239.
   Web of Science ®Google Scholar
• Bosworth H. Challenges and strategies to improve patient health literacy and competencies. Patient Intell. 2010;2:19–25.
   Google Scholar
• Schmid-Ott G, Schallmayer S, Calliess IT. Quality of life in patients with psoriasis and psoriasis arthritis with a special focus on stigmatization experience. Clin Dermatol. 2007;25:547–554.
   PubMed Web of Science ®Google Scholar